Xiao-Yan Wang Selected Research

Breast Neoplasms (Breast Cancer)

1/2021	Suppression Of Aberrant Activation Of NF-κB Pathway In Drug-resistant Leukemia Stem Cells Contributes To Parthenolide-potentiated Reversal Of Drug Resistance In Leukemia.
2/2019	Combined effects of GSTM1 and GSTT1 polymorphisms on breast cancer risk: A MOOSE-compliant meta-analysis and false-positive report probabilities test.
1/2015	Relation between qualitative and quantitative 3-dimensional ultrasound and ki-67 expression in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Yan Wang Research Topics

Disease

34	Neoplasms (Cancer) 04/2022 - 03/2003
11	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 08/2003
10	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2005
7	Hepatocellular Carcinoma (Hepatoma) 08/2019 - 03/2003
7	Carcinogenesis 11/2016 - 11/2007
6	Infections 09/2020 - 12/2008
4	Obesity 02/2022 - 08/2011
4	Carcinoma (Carcinomatosis) 11/2021 - 03/2003
4	Hepatitis B 03/2021 - 03/2004
3	Coronary Disease (Coronary Heart Disease) 07/2021 - 08/2015
3	Fatty Liver 01/2021 - 01/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2012
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2015
3	Stomach Neoplasms (Stomach Cancer) 11/2020 - 12/2010
3	Inflammation (Inflammations) 01/2019 - 03/2016
3	Liver Neoplasms (Liver Cancer) 01/2019 - 01/2018
3	Hypertension (High Blood Pressure) 06/2018 - 08/2014
3	Hyperlipidemias (Hyperlipidemia) 05/2018 - 01/2013
3	Hepatomegaly 01/2017 - 09/2012
3	Necrosis 07/2014 - 02/2008
3	Colonic Neoplasms (Colon Cancer) 01/2013 - 05/2008
2	Adenocarcinoma 04/2022 - 06/2008
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2021
2	Diarrhea 07/2021 - 01/2020
2	Leukemia 01/2021 - 11/2016
2	Overweight 01/2021 - 01/2020
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 12/2019
2	COVID-19 09/2020 - 01/2020
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2019 - 01/2016
2	Heart Failure 05/2018 - 10/2016
2	Ulcerative Colitis 01/2018 - 12/2007
2	Pain (Aches) 01/2016 - 02/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2015 - 02/2008
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2014 - 03/2013
2	Rheumatoid Arthritis 01/2014 - 12/2009
2	Flushing 12/2013 - 03/2010
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2011 - 09/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2010 - 03/2009
2	Reperfusion Injury 02/2008 - 12/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2008 - 12/2007
2	Ascites 11/2007 - 07/2007
1	Seasonal Allergic Rhinitis (Hay Fever) 12/2022
1	Allergic Rhinitis 12/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022
1	Cognitive Dysfunction 03/2022
1	Noncommunicable Diseases 02/2022

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2007
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2009
6	LipidsIBA 01/2019 - 01/2013
5	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 03/2003
5	Pharmaceutical PreparationsIBA 01/2021 - 10/2003
5	MicroRNAs (MicroRNA)IBA 11/2020 - 12/2010
5	Biological ProductsIBA 01/2018 - 11/2007
4	Long Noncoding RNAIBA 01/2022 - 03/2016
4	EnzymesIBA 01/2020 - 08/2011
4	Glucose (Dextrose)FDA LinkGeneric 10/2016 - 11/2007
3	CytokinesIBA 03/2022 - 09/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2013
3	Celecoxib (Celebrex)FDA Link 01/2021 - 03/2009
3	CholesterolIBA 01/2019 - 01/2013
3	Phosphotransferases (Kinase)IBA 01/2018 - 01/2015
3	Contrast MediaIBA 01/2017 - 02/2008
3	Small Interfering RNA (siRNA)IBA 09/2015 - 05/2008
3	Fenofibrate (CiL)FDA LinkGeneric 01/2015 - 09/2012
2	CollagenIBA 03/2022 - 01/2021
2	CaspasesIBA 01/2022 - 10/2014
2	Propofol (Diprivan)FDA LinkGeneric 11/2021 - 08/2013
2	VaccinesIBA 03/2021 - 01/2015
2	N-methyladenosineIBA 01/2021 - 12/2019
2	SugarsIBA 01/2021 - 10/2016
2	6-methyladenineIBA 01/2021 - 12/2019
2	Indicators and Reagents (Reagents)IBA 09/2020 - 09/2014
2	RNA (Ribonucleic Acid)IBA 12/2019 - 01/2015
2	Alanine Transaminase (SGPT)IBA 01/2019 - 08/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 12/2009
2	Therapeutic UsesIBA 05/2018 - 08/2011
2	Transcription Factors (Transcription Factor)IBA 09/2017 - 11/2013
2	Messenger RNA (mRNA)IBA 09/2017 - 08/2003
2	schizandrin BIBA 01/2017 - 01/2013
2	Bile Acids and Salts (Bile Acids)IBA 01/2015 - 01/2013
2	Collagenases (Collagenase)FDA Link 12/2013 - 03/2010
2	Monoclonal AntibodiesIBA 01/2013 - 07/2007
2	2'3'-didehydro-2'3'-dideoxyadenosineIBA 03/2008 - 12/2007
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2022
1	TankyrasesIBA 04/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2022
1	Riluzole FDA LinkGeneric 03/2022
1	Excitatory Amino Acid Transporter 3IBA 03/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2022
1	LigandsIBA 03/2022
1	CCR5 Receptors (CCR5 Receptor)IBA 03/2022
1	Hematoxylin (Haematoxylon)IBA 03/2022
1	CC ChemokinesIBA 03/2022
1	TeaIBA 02/2022

Therapy/Procedure

11	Therapeutics 02/2022 - 10/2004
4	Drug Therapy (Chemotherapy) 11/2016 - 09/2007
2	Stents 07/2021 - 01/2021
2	Catheters 01/2021 - 08/2014
1	Immunotherapy 12/2022